Statement Of Financial Position [Abstract]

Medistim - Filing #2616656

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
58 862 NOK
64 684 NOK
Deferred tax assets
3 240 NOK
775,000 NOK
Cash and cash equivalents
124 866 NOK
65 761 NOK
Assets
403 244 NOK
345 820 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 585 NOK
4 585 NOK
Retained earnings
240 160 NOK
203 899 NOK
Share premium
41 852 NOK
41 852 NOK
Treasury shares
27,000 NOK
33,000 NOK
Other reserves
6 138 NOK
781,000 NOK
Equity
27,000 NOK
240 160 NOK
6 138 NOK
13 344 NOK
306 052 NOK
246 298 NOK
59 754 NOK
41 852 NOK
4 585 NOK
203 899 NOK
204 680 NOK
52 165 NOK
5 762 NOK
4 585 NOK
33,000 NOK
781,000 NOK
41 852 NOK
256 846 NOK
1 746 NOK
4 330 NOK
41 852 NOK
236 861 NOK
186 130 NOK
50 730 NOK
184 384 NOK
36,000 NOK
4 585 NOK
Liabilities [abstract]
Liabilities
97 192 NOK
88 974 NOK
Equity and liabilities
403 244 NOK
345 820 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.